Survanta (AbbVie Inc.)
Welcome to the PulseAid listing for the Survanta drug offered from AbbVie Inc.. This Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Beractant |
| SUBSTANCE NAME: | BERACTANT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA] |
| ROUTE: | ENDOTRACHEAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1991-07-01 |
| END MARKETING DATE: | 0000-00-00 |
Survanta HUMAN PRESCRIPTION DRUG Details:
| Item Description | Survanta from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/mL) |
| START MARKETING DATE: | 1991-07-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0074-1040_76876f21-08b6-9dfe-8dda-901496585239 |
| PRODUCT NDC: | 0074-1040 |
| APPLICATION NUMBER: | NDA020032 |
Other BERACTANT Pharmaceutical Manufacturers / Labelers:
